Published in J Neurogastroenterol Motil on April 30, 2014
Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy (2010) 7.10
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med (2011) 6.76
Classification of oesophageal motility abnormalities. Gut (2001) 4.86
Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol (2011) 3.66
The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25
ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol (2013) 3.20
Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med (1995) 3.00
Treatment of achalasia and related motor disorders. Gastroenterology (1980) 2.68
Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology (2013) 2.67
Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol (2006) 2.65
Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology (1992) 2.53
Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut (2002) 2.39
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
Treatment of achalasia with pneumatic dilatations. Gut (1971) 2.26
Laparoscopic cardiomyotomy for achalasia. J R Coll Surg Edinb (1991) 1.94
Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure. Ann Surg (2012) 1.90
Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol (1999) 1.74
Surgical treatment of achalasia: current status and controversies. Dig Surg (2004) 1.68
Achalasia. Lancet (2013) 1.49
Graded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasia. Am J Gastroenterol (1993) 1.41
Management of achalasia: surgery or pneumatic dilation. Gut (2011) 1.33
Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol (2004) 1.30
Peroral endoscopic myotomy for treatment of achalasia: initial results of a korean study. Clin Endosc (2013) 1.21
Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation. J Gastrointest Surg (2009) 1.20
Achalasia. Best Pract Res Clin Gastroenterol (2007) 1.13
Modern management of achalasia. Curr Treat Options Gastroenterol (2005) 1.08
Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci (1996) 1.05
24-h pH monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomy. Aliment Pharmacol Ther (2010) 1.05
A review of factors predicting outcome of pneumatic dilation in patients with achalasia cardia. J Neurogastroenterol Motil (2011) 1.04
Laparoscopic myotomy: technique and efficacy in treating achalasia. Gastrointest Endosc Clin N Am (2001) 1.03
Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol (2004) 1.03
Factors determining successful outcome following pneumatic balloon dilation in achalasia cardia. Indian J Gastroenterol (2006) 1.01
Long-term results of graded pneumatic dilatation under endoscopic guidance in patients with primary esophageal achalasia. World J Gastroenterol (2004) 0.96
Endoscopic pneumatic balloon dilation in primary achalasia: predictive factors, complications, and long-term follow-up. Dis Esophagus (2008) 0.89
Pneumatic dilation for achalasia cardia: reduction in lower esophageal sphincter pressure in assessing response and factors associated with recurrence during long-term follow up. Dig Endosc (2011) 0.89
Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer. Endoscopy (2015) 1.50
[Clinical features and predictive factors of acute hepatitis A complicated with acute kidney injury]. Korean J Gastroenterol (2010) 1.41
Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer (2014) 1.31
Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology (2002) 1.19
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy. BMC Cancer (2011) 1.08
Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc (2014) 1.02
Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter (2003) 1.01
Long-term outcome of capsule endoscopy in obscure gastrointestinal bleeding: a nationwide analysis. Endoscopy (2013) 0.97
A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer. PLoS One (2016) 0.95
Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching. J Gastroenterol Hepatol (2014) 0.92
Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study. Am J Gastroenterol (2016) 0.92
Stricture occurring after endoscopic submucosal dissection for esophageal and gastric tumors. Clin Endosc (2014) 0.89
Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria. Dig Dis Sci (2014) 0.89
Lactate Parameters Predict Clinical Outcomes in Patients with Nonvariceal Upper Gastrointestinal Bleeding. J Korean Med Sci (2017) 0.88
Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Liver Int (2013) 0.88
Management strategy for small duodenal carcinoid tumors: does conservative management with close follow-up represent an alternative to endoscopic treatment? Digestion (2013) 0.84
Effect of DA-9701 on colorectal distension-induced visceral hypersensitivity in a rat model. Gut Liver (2014) 0.83
The Role of Microbiota on the Gut Immunology. Clin Ther (2015) 0.82
EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer. Mol Carcinog (2015) 0.82
Limited role of bone marrow aspiration and biopsy in the initial staging work-up of gastric mucosa-associated lymphoid tissue lymphoma in Korea. Gut Liver (2014) 0.81
Endoscopic Resection for Early Gastric Cancer beyond Absolute Indication with Emphasis on Controversial Issues. J Gastric Cancer (2014) 0.81
[Guidelines of prevention and treatment for NSAID-related peptic ulcers]. Korean J Gastroenterol (2009) 0.81
Two Distinct Types of Hypercontractile Esophagus: Classic and Spastic Jackhammer. Gut Liver (2016) 0.81
Impact of Carcinomatosis on Clinical Outcomes after Self-Expandable Metallic Stent Placement for Malignant Gastric Outlet Obstruction. PLoS One (2015) 0.80
Does Back-To-Back Capsule Endoscopy Increase the Diagnostic Yield over a Single Examination in Patients with Obscure Gastrointestinal Bleeding? Gut Liver (2010) 0.80
Is a second-look endoscopy necessary after endoscopic submucosal dissection for gastric neoplasm? Gut Liver (2015) 0.80
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens. Oncotarget (2015) 0.80
Short-Term Outcomes of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Prospective Multicenter Cohort Study. Gut Liver (2016) 0.80
The Role of Capsule Endoscopy in Patients with Obscure Gastrointestinal Bleeding. Clin Endosc (2016) 0.79
Treatment of noncardiac chest pain. J Gastroenterol Hepatol (2005) 0.79
Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study. Gut Liver (2017) 0.79
Prophylactic pancreatic stent placement for endoscopic duodenal ampullectomy: a single-center retrospective study. Gut Liver (2014) 0.78
Recurrence and Its Impact on the Health-related Quality of Life in Patients with Gastroesophageal Reflux Disease: A Prospective Follow-up Analysis. J Neurogastroenterol Motil (2016) 0.78
Endoscopic Submucosal Dissection for Early Gastric Neoplasia Occurring in the Remnant Stomach after Distal Gastrectomy. Clin Endosc (2016) 0.78
Diabetic biomarkers and the risk of proximal or distal gastric cancer. J Gastroenterol Hepatol (2016) 0.77
Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial. PLoS One (2015) 0.77
Delayed Perforation Occurring after Endoscopic Submucosal Dissection for Early Gastric Cancer. Clin Endosc (2015) 0.77
Expanding indications of endoscopic submucosal dissection for early gastric cancer: hope or hype? Gut Liver (2015) 0.77
One-dimensional and 2-dimensional tumor size measurement for prediction of lymph node metastasis in differentiated early gastric cancer with minute submucosal invasion. Gastrointest Endosc (2016) 0.76
Multidrug-Resistant Tuberculous Mediastinal Lymphadenitis, with an Esophagomediastinal Fistula, Mimicking an Esophageal Submucosal Tumor. Clin Endosc (2016) 0.75
Clinical Predictors for Migraine in Patients Presenting With Nausea and/or Vomiting. J Neurogastroenterol Motil (2013) 0.75
Prevalence of Extraesophageal Symptoms in Patients With Gastroesophageal Reflux Disease: A Multicenter Questionnaire-based Study in Korea. J Neurogastroenterol Motil (2013) 0.75
Esophagogastric Junction Outflow Obstruction Transformed to Type II Achalasia. J Neurogastroenterol Motil (2016) 0.75
Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep (2016) 0.75
The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D). Therap Adv Gastroenterol (2015) 0.75
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
Nitrergic Pathway Is the Main Contributing Mechanism in the Human Gastric Fundus Relaxation: An In Vitro Study. PLoS One (2016) 0.75
Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain. Gut Liver (2016) 0.75
A Comparative Randomized Trial on the Optimal Timing of Dexamethasone for Pain Relief after Endoscopic Submucosal Dissection for Early Gastric Neoplasm. Gut Liver (2016) 0.75
Negative Biopsy after Referral for Biopsy-Proven Gastric Cancer. Gut Liver (2016) 0.75
The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study. Gut Liver (2016) 0.75